LONDON, April 4, 2016 /PRNewswire/ -- This BCC Research report provides an overview of the current and future global market for drug repurposing. Includes forecast through 2020.
Use this report to:
Analyze the global market for repurposed drugs by application, by usage, and used orally or intravenously.
Analyze the various trends, mergers and acquisitions within the repurposed drug market.
Gain information about the regulatory environment, technologies, market projections and market shares for repurposed drug market.
Gain information about the usage of repurposed drugs in central nervous disorders, cardiovascular disorders, oncology, metabolic, autoimmune, and other disorders.
The global market for drug repurposing will grow from nearly $24.4 billion in 2015 to nearly $31.3 billion by 2020, with a compound annual growth rate (CAGR) of 5.1% for the period of 2015-2020.
The U.S. dominated the drug repurposing market and should reach approximately $13.7 in 2015 and close to $17.9 billion by 2020, rising at a CAGR of 5.4%.
The non-U.S. market is expected to increase from $ 10.6 billion in 2015 to nearly $13.4 billion by 2020 with a CAGR of 4.7%.
STUDY GOALS AND OBJECTIVES
Drug repurposing is the one of the major revolutions taking place in the pharmaceutical industry. Advancements in technologies such as bioinformatics, genomics and proteomics are making drug repositioning possible. Drug
repositioning/repurposing reduces development costs and time, improves return on investment and also facilitates the rescue of previously failed compounds.
BCC Research's goal in conducting this study is to provide an overview of the current and future global market for drug repurposing. The key objective is to present a comprehensive analysis and outline the future direction of drug repurposing as an important change in the process of drug development. The report discusses market
improvements, setbacks and demands and compares the use of this type of development.
Through a detailed analysis of the structure of the drug repurposing industry, the revenues have been broken down intoU.S.and non-U.S. sectors. Sales figures are estimated for the five-year period from 2015 through 2020.
Applications for drug repurposing are also discussed, with an emphasis on the use of the inhibitors in therapeutic categories and various disease sectors. The report also covers significant patents and their allotments in each category.
SCOPE OF THE REPORT
This report provides a global overview of drug repurposing, also known as repositioning or reprofiling, including the techniques and applications in various therapies. The report deals with the global market for repurposed drugs in three main areas: market by application of repurposed drugs, by usage of repurposed drugs and by application
site (i.e., whether they are used orally or intravenously). The application area is divided into types of disorders (i.e., repurposed drugs in central nervous disorders, cardiovascular disorders, oncology, metabolic, autoimmune and other disorders).
Market by usage is analyzed on the basis that repurposed drugs are used alone in single therapy or used in combination with other drugs.
Excluded from this report are drugs that are not yet approved as repurposed drugs.
BCC Research analyzes the market and its applications, regulatory environment, technologies involved, market projections and market shares. The market is mainly divided into theU.S.and the rest of the world (ROW).
Also included in the report are relevant patent analysis and comprehensive profiles of the leading companies in the drug repurposing market. The key players are Novartis AG, Abbott Healthcare, Pfizer Inc., Johnson & Johnson and Hoffmann-La Roche. Other significant players are the generic drug manufacturers such as Sandoz, Mylan Inc., and Teva Pharmaceuticals. The chapter on company profiles also includes even core drug
repurposing companies such as SOM Biotech, Biovista Inc. and Sosei Group Ltd.
Download the full report: https://www.reportbuyer.com/product/3523241/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-markets-for-drug-repurposing-300245817.html